Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis.

Authors:
Hu H; Cao M; Sun Y; Jin X; Zhao X and 1 more

Journal:
Int J Hypertens

Publication Year: 2023

DOI:
10.1155/2023/6683987

PMCID:
PMC10019978

PMID:
36938116

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Hypertens

Abbreviation: Int J Hypertens

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Peripheral Vascular Disease

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Da-Chuan-Xiong Decoction Ameliorates Sodium Sensitivity and Plasma Norepinephrine via Attenuation o…
Zhang Q; Li H; Zhao S and 2 more (2024) - Transparency Score: 3/6
Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypert…
Preeti; Sambhakar S; Malik R and 7 more (2024) - Transparency Score: 2/6
Comorbidity of Anxiety and Hypertension: Common Risk Factors and Potential Mechanisms.
Qiu T; Jiang Z; Chen X and 2 more (2023) - Transparency Score: 3/6
Evaluation of Arterial Stiffness and Its Relation to Innovative Anthropometric Indices in Persian A…
Ataee Z; Aghaee A; Sobhani SR and 5 more (2023) - Transparency Score: 3/6
Evaluation of Mean Platelet Volume in Children with Hypertension.
Yildiz I; Kizilca O. (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that there are no conflicts of interest in this manuscript."

Evidence found in paper:

"The authors would like to thank the authors of the articles for their contributions to this study. This manuscript was supported by the Project of Invigorating Healthcare through the Science and Technology Program of Suzhou Municipal Science and Technology Bureau (No. KJXW2021029)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025